U.S. Health Secretary Robert F. Kennedy Jr. emphasized during an interview on Fox News’ Special Report with Bret Baier that the Trump administration has no plans to restrict access to vaccines. Kennedy clarified that Americans who want vaccines will continue to have them, countering concerns about possible changes to national health policy.
Addressing recent speculation, Kennedy underscored that the administration supports medical freedom while maintaining access to essential healthcare. He stated that while the government may evaluate certain programs, it will not remove the option for citizens who choose vaccination. This assurance comes at a time when vaccine policy remains a sensitive and highly debated topic in the U.S.
Kennedy’s remarks are intended to reassure families, healthcare providers, and public health advocates who fear potential shifts in vaccine distribution. He noted that the government recognizes the importance of vaccines in preventing disease outbreaks and protecting vulnerable populations. At the same time, the administration aims to respect individual choice, striking a balance between public health priorities and personal freedoms.
The Health Secretary’s statement aligns with broader efforts to ensure transparency and trust between the government and the public. By directly addressing concerns on a national platform, Kennedy sought to reaffirm that vaccines will remain readily available for those who want them, without interference or restriction.
As debates over vaccine policy continue, Kennedy’s comments highlight the administration’s commitment to both accessibility and choice, assuring Americans that their healthcare decisions will remain in their own hands.


FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement
Japan Approves $117 Billion Budget to Power Stimulus and Support Growth
Trump and Lula Discuss Trade, Sanctions, and Security in “Productive” Phone Call
Trump Administration Tightens H-1B Visa Vetting With New Focus on Free Speech and Censorship
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
Trump Warns Drug-Trafficking Nations as Colombia’s Petro Issues Strong Rebuttal
U.S. Officials Say Afghan Suspect in D.C. National Guard Shooting Radicalized After Arrival
Trump’s Name Appears on U.S. Institute of Peace Ahead of Rwanda–Congo Deal Signing
Trump Calls for Permanent Pause on Migration After National Guard Shooting Near White House
EU Prepares Antitrust Probe Into Meta’s AI Integration on WhatsApp
New Orleans Immigration Crackdown Sparks Fear as Federal Arrests Intensify
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition
Federal Judge Blocks Trump Administration’s Medicaid Funding Restrictions Targeting Planned Parenthood
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
Australia Progresses AUKUS Review as U.S. Affirms Strong Support 



